相关实验视频
Updated: Jun 17, 2025

04:16
Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
12.7K
一种极其广泛的QRS复杂性心动减速,由阿纳莫雷林诱导
Kazuki Shimojo1, Yasunori Kanzaki1, Hiroyuki Miyazawa1
1Department of Cardiology Ogaki Municipal Hospital Ogaki Japan.
Journal of arrhythmia
|August 14, 2024
概括
亚纳莫雷林是一种格林受体激动剂,可以引起危险的心律问题. 早期心电图监测和及时治疗对于疑似阿纳莫雷林毒性患者至关重要,特别是那些肝脏问题患者.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 亚纳莫雷林是一种林受体激活剂,用于治疗与癌症相关的缓冲症.
- 虽然有效,但阿纳莫雷林有诱导危及生命的心律失常的风险.
- 癌症缓解症显著影响患者的生活质量和治疗结果.
研究的目的:
- 介绍一例病例研究,该病例研究的患者经历了二次性严重心律失常后的anamorelin管理.
- 为了突出与阿纳莫雷林诱导的广QRS心动减速症相关的诊断挑战.
- 强调警的心电图 (ECG) 监测和在疑似发生阿纳莫雷林毒性病例时迅速管理的重要性.
主要方法:
- 一个详细的病例报告,一个病人用阿纳莫雷林治疗癌症缓冲症.
- 审查患者的临床表现,心电图发现和实验室结果.
- 分析患者对停用阿纳莫雷林和支持性护理的反应.
主要成果:
- 患者出现了极其广泛的QRS心动减速,呈现出严重的诊断困难.
- 停用阿纳莫雷林导致心律正常化和QRS持续时间.
- 这一案例强调了阿纳莫雷林与严重心室节律失常之间的潜在联系.
结论:
- 亚纳莫雷林可以导致严重的心律不整,包括广泛的QRS低心率.
- 持续的心电图监测对于接受阿纳莫雷林的患者至关重要,特别是那些肝功能受损的患者.
- 迅速停止药物和适当的血液动力学支持对于管理疑似阿纳莫雷林诱导的心脏毒性至关重要.
相关概念视频
Mechanism of Cardiac Arrhythmias
903
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
903
Increased pulse rate
651
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
651
Disturbances in Heart Rhythm
922
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
922
Regulation of Heart Rates
1.7K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
1.7K
Cardiac Action Potential
1.2K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
1.2K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
940
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
940

